UPL Ltd
NSE:UPL
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
451.9
621.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
UPL Ltd
Current Assets | 377.9B |
Cash & Short-Term Investments | 47.3B |
Receivables | 162B |
Other Current Assets | 168.7B |
Non-Current Assets | 473.4B |
Long-Term Investments | 18.4B |
PP&E | 103.2B |
Intangibles | 312.6B |
Other Non-Current Assets | 39.3B |
Current Liabilities | 279.2B |
Accounts Payable | 142.3B |
Short-Term Debt | 77B |
Other Current Liabilities | 59.9B |
Non-Current Liabilities | 302.7B |
Long-Term Debt | 230.4B |
Other Non-Current Liabilities | 72.4B |
Balance Sheet
UPL Ltd
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
5 340
|
7 240
|
16 380
|
16 950
|
28 260
|
67 240
|
47 970
|
57 970
|
59 670
|
59 430
|
|
Cash |
5 340
|
7 240
|
16 380
|
16 950
|
22 230
|
58 580
|
38 190
|
39 650
|
44 840
|
51 820
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
6 030
|
8 660
|
9 780
|
18 320
|
14 830
|
7 610
|
|
Short-Term Investments |
5 200
|
4 320
|
12 430
|
11 780
|
50
|
30
|
390
|
11 180
|
1 300
|
3 040
|
|
Total Receivables |
48 650
|
62 070
|
66 070
|
75 720
|
146 820
|
140 890
|
154 700
|
196 250
|
218 390
|
201 760
|
|
Accounts Receivables |
41 420
|
51 000
|
56 560
|
60 560
|
116 790
|
118 670
|
125 910
|
158 430
|
183 050
|
166 990
|
|
Other Receivables |
7 230
|
11 070
|
9 510
|
15 160
|
30 030
|
22 220
|
28 790
|
37 820
|
35 340
|
34 770
|
|
Inventory |
34 290
|
37 870
|
41 560
|
45 380
|
91 330
|
78 500
|
94 220
|
130 780
|
139 850
|
127 760
|
|
Other Current Assets |
1 520
|
570
|
540
|
410
|
760
|
5 750
|
3 420
|
1 100
|
1 070
|
1 290
|
|
Total Current Assets |
95 000
|
112 070
|
136 980
|
150 240
|
267 220
|
292 410
|
300 700
|
397 280
|
420 280
|
393 280
|
|
PP&E Net |
21 820
|
26 000
|
31 160
|
39 640
|
58 560
|
72 970
|
80 460
|
92 620
|
102 670
|
108 140
|
|
PP&E Gross |
21 820
|
26 000
|
31 160
|
39 640
|
58 560
|
72 970
|
80 460
|
92 620
|
102 670
|
108 140
|
|
Accumulated Depreciation |
19 820
|
22 830
|
24 390
|
28 110
|
43 660
|
52 290
|
57 780
|
61 040
|
70 860
|
79 150
|
|
Intangible Assets |
14 100
|
13 290
|
13 280
|
13 600
|
115 210
|
118 560
|
111 470
|
110 680
|
113 660
|
110 230
|
|
Goodwill |
4 130
|
4 170
|
4 190
|
4 320
|
166 270
|
182 410
|
176 890
|
183 640
|
198 980
|
201 840
|
|
Note Receivable |
4 230
|
5 900
|
7 720
|
7 000
|
10 030
|
11 560
|
12 320
|
9 270
|
5 680
|
5 300
|
|
Long-Term Investments |
2 720
|
3 360
|
3 780
|
10 340
|
7 060
|
5 580
|
5 810
|
10 820
|
15 780
|
18 930
|
|
Other Long-Term Assets |
3 050
|
5 090
|
6 700
|
5 290
|
7 310
|
17 340
|
16 660
|
22 480
|
28 720
|
37 740
|
|
Other Assets |
4 130
|
4 170
|
4 190
|
4 320
|
166 270
|
182 410
|
176 890
|
183 640
|
198 980
|
201 840
|
|
Total Assets |
145 050
N/A
|
169 880
+17%
|
203 810
+20%
|
230 430
+13%
|
631 660
+174%
|
700 830
+11%
|
704 310
+0%
|
826 790
+17%
|
885 770
+7%
|
875 460
-1%
|
|
Liabilities | |||||||||||
Accounts Payable |
33 950
|
39 540
|
48 750
|
56 750
|
98 470
|
102 330
|
125 250
|
165 520
|
176 140
|
156 840
|
|
Accrued Liabilities |
630
|
790
|
1 630
|
590
|
9 490
|
10 270
|
10 850
|
17 320
|
16 560
|
11 500
|
|
Short-Term Debt |
15 630
|
0
|
0
|
0
|
24 780
|
12 980
|
14 140
|
40 190
|
11 060
|
42 330
|
|
Current Portion of Long-Term Debt |
6 180
|
29 920
|
10 110
|
7 650
|
2 790
|
1 310
|
2 660
|
3 610
|
19 010
|
3 580
|
|
Other Current Liabilities |
9 350
|
11 430
|
9 790
|
11 430
|
27 080
|
39 970
|
43 370
|
55 320
|
67 600
|
54 360
|
|
Total Current Liabilities |
65 740
|
81 680
|
70 280
|
76 420
|
162 610
|
166 860
|
196 270
|
281 960
|
290 370
|
268 610
|
|
Long-Term Debt |
17 930
|
22 660
|
53 500
|
58 730
|
263 830
|
279 570
|
227 260
|
222 310
|
208 190
|
249 680
|
|
Deferred Income Tax |
980
|
1 190
|
1 690
|
880
|
21 970
|
27 770
|
26 620
|
24 750
|
24 620
|
24 060
|
|
Minority Interest |
480
|
440
|
330
|
190
|
34 540
|
33 120
|
36 930
|
46 470
|
55 850
|
49 130
|
|
Other Liabilities |
6 350
|
5 020
|
4 040
|
2 520
|
1 560
|
690
|
8 360
|
4 690
|
8 300
|
6 050
|
|
Total Liabilities |
91 480
N/A
|
110 990
+21%
|
129 840
+17%
|
138 740
+7%
|
484 510
+249%
|
508 010
+5%
|
495 440
-2%
|
580 180
+17%
|
587 330
+1%
|
597 530
+2%
|
|
Equity | |||||||||||
Common Stock |
860
|
860
|
1 830
|
1 020
|
1 020
|
1 530
|
1 530
|
1 530
|
1 500
|
1 500
|
|
Retained Earnings |
5 070
|
12 080
|
27 400
|
44 170
|
108 650
|
125 620
|
148 400
|
175 910
|
224 460
|
202 990
|
|
Additional Paid In Capital |
8 220
|
8 220
|
44 980
|
46 070
|
46 070
|
45 940
|
45 940
|
45 940
|
32 420
|
32 420
|
|
Other Equity |
39 420
|
37 730
|
240
|
430
|
8 590
|
19 730
|
13 000
|
23 230
|
40 060
|
41 020
|
|
Total Equity |
53 570
N/A
|
58 890
+10%
|
73 970
+26%
|
91 690
+24%
|
147 150
+60%
|
192 820
+31%
|
208 870
+8%
|
246 610
+18%
|
298 440
+21%
|
277 930
-7%
|
|
Total Liabilities & Equity |
145 050
N/A
|
169 880
+17%
|
203 810
+20%
|
230 430
+13%
|
631 660
+174%
|
700 830
+11%
|
704 310
+0%
|
826 790
+17%
|
885 770
+7%
|
875 460
-1%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
643
|
643
|
761
|
764
|
764
|
764
|
764
|
764
|
783
|
783
|
|
Preferred Shares Outstanding |
0
|
0
|
82
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|